Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Haitai Pharmaceutical Technology is a comprehensive pharmaceutical research and development enterprise based in Jinan, China, specializing in both innovative drug discovery and high-end generic drug development. Established in 2003, the company operates as a high-tech Contract Research Organization (CRO) providing a wide range of services including medicinal chemistry, process chemistry, and clinical trial management. Its internal product portfolio focuses primarily on small molecule therapeutics for cardiovascular, metabolic, and oncological indications. Haitai is recognized for its strong chemical synthesis capabilities and has successfully brought several complex generic products to the Chinese market. The company serves as a key player in the regional biotech ecosystem, bridging the gap between early-stage research and commercial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinan Haitai Pharmaceutical Technology.